Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting

Fig. 2

Trends in the overall and genotyping success rates of DBS and plasma specimens from 2016 to 2019. Overall genotyping success rates (GSR) were obtained by analysing all specimens genotyped in the 4 years (2016–2019). The GSR was a proportion of specimens that yielded clean sequences (genotypes) with the denominator being the total number of specimens that we attempted to genotype in that year or in all the 4 years for the overall GSR (see Table 1 for denominator values). The analysis was also independently done for DBS and plasma specimens

Back to article page